Standardization of prothrombin time for laboratory control of oral anticoagulant therapy

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 1, 1999, Pages 17-26

  Kitchen, Steven ^a   Preston, F Eric ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

INR; ISI; Oral anticoagulants; Prothrombin time; Standardization

Indexed keywords

ANTICOAGULANT AGENT; THROMBOPLASTIN;

ANTICOAGULANT THERAPY; ARTICLE; ARTIFACT REDUCTION; CALIBRATION; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTHROMBIN TIME; STANDARDIZATION; VALIDATION PROCESS;

EID: 0032963674     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996419     Document Type: Article

References (62)

1. 1. Quick A. The prothrombin time in hemophilia and jaundice. J Biol Chem 1935;109:73-74
2. 2. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemostas 1991;66:67-69
3. 3. Morrisey JH, Fair DS, Edgington TS. Monoclonal analysis of purified and cell-associated tissue factor. Thromb Res 1988; 52:247-261
4. 4. Bauer KA, Kass BL, ten Cate H, et al. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990;76:731-736
5. 5. Marder VJ, Shulman NR. Clinical aspects of congenital factor VII deficiency. Am J Med 1964;37:182-194
6. 6. Poller L, Taberner DA. Dosage and control of oral anticoagulants: An international study. Br J Haematol 1982;51:479-485
7. 7. Denson KWE. Thromboplastin - Sensitivity precision and other characteristics. Clin Lab Haematol 1988;10:315-328
8. 8. Hirsh J, Levine M. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America. Thromb Haemostas 1988;59:129-132
9. 9. Biggs R, Denson KWE. Second report on the standardisation of the prothrombin time for oral anticoagulant control. Thromb Diath Haemorragh 1966;20(Suppl.):345-361
10. 10. Miale JB. The use of reference plasmas in the control of oral anticoagulant therapy. In: Triplett DA, ed. Standardisation of Coagulation Assays: An Overview. Skokie, IL: College of American Pathologists; 1982:23-38
11. 11. Miale JB, LaFond D. Prothrombin time standardisation. Am J Clin Pathol 1969;52:154-160
12. 12. Hermans J, Van den Besselaar AMHP, Loeliger EA, Van der Velde EA. A collaborative study of reference materials for thromboplastins. Thromb Haemostas 1983;50:712-717
13. 13. WHO expert committee on biological standardisation. Thirty Third report. WHO Technol Rep Series 1983;687:81-105
14. 14. Thomson JM, Tomenson JA, Poller L. The calibration of the second primary International reference preparation for thromboplastin (Thromboplastin Human Plain coded BCT/253). Thromb Haemostas 1984;52:336-342
15. 15. Kirkwood TBL. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemostas 1983;49:238-244
16. 16. Guidelines For Thromboplastin and Plasma Used to Control Oral Anticoagulant Therapy, 1999; WHO (in press)
17. 17. Van den Besselaar AMHP, Bertina RM. Multi-centre calibration of the secondary reference material for thromboplastin rabbit plain coded CRM 149R. Thromb Haemostas 1991:65:263-267
18. 18. Van den Besselaar AMHP. Multi-centre study of replacement of the international reference preparation for thromboplastin rabbit plain. Thromb Haemostas 1993;70:794-799
19. 19. Thomson JM, Parby KV, Poller L. Calibration of BCT/441 the ICSH reference preparation for thromboplastin. Thromb Haemostas 1986;55:379-382
20. 20. Duncan EM, Casey CR, Duncan BM, Lloyd JV. Effect of concentration of trisodium citrate anticoagulant on calculation of the INR and the ISI of thromboplastin. Thromb Haemostas 1994; 72:84-88
21. 21. Van den Besselaar AMHP, Lewis SM, Mannucci PM, Poller L. Status of present and candidate International Reference Preparations of thromboplastin for prothrombin time. Thromb Haemostas 1993;69:85
22. 22. Burgess-Wilson MR, Buri R, Woodhams B. Important differences encountered in the normal plasma pools used for the control of oral anticoagulation. Thromb Haemostas 1993; 69(Abst):1124
23. 23. Lang H, Spaethe R, Beeser H, et al. Calibration of a lyophilised pooled plasma as candidate reference plasma for standardisation of the prothrombin time ratio. Haemostaseologie 1993; 13:96-105
24. 24. Peters RHM, Van den Besselaar AMHP, Olthuis FMFG. Determination of the mean normal prothrombin time for assessment of INRs. Usefulness of lyophilised plasma. Thromb Haemostas 1994;66:442-445
25. 25. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% and 3.8% sodium citrate concentrations on routine coagulation testing. Am J Clin Pathol 1997;107:105-110
26. 26. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants: Mechanism of action clinical effectiveness and optimal therapeutic range. Chest 1995;104(Suppl):231S-246S
27. 27. ICTH/ICSH. Prothrombin time standardisation: Report of the expert panel on oral anticoagulant control. Thromb Haemostas 1979;42:1073-1114
28. 28. Evatt BL, Brogan D, Triplett D, et al. Effect of thromboplastin and instrumentation on the prothrombin time test. Clin Lab Haemostas 1981;3:331-342
29. 29. Starr H, Rhoades P, Lam-Po-Tang PR, Archer GT. Prothrombin times: An evaluation of four thromboplastins and four machines. Pathology 1980;12:597-574
30. 30. Poggio M, Van den Besselaar AMHP, Van der Velde EA, Bertina RM. The effects of some instruments for PT testing on the ISI of two rabbit brain thromboplastin reagents. Thromb Haemostas 1988;62:868-874
31. 31. D'Angelo A, Seveso MP, D'Angelo SV, et al. Comparison of two automated coagulometers and the manual tilt tube method for the determination of the prothrombin time. Am J Clin Pathol 1989;92:321-328
32. 32. Ray MJ, Smith IR. The dependence of the ISI on the coagulometer used to perform the prothrombin time. Thromb Haemostas 1990;63:424-429
33. 33. Bader R, Mannucci PM, Tripodi A, et al. Multi-centric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemostas 1984;71: 292-299
34. 34. Thomson JM, Taberner DA, Poller L. Automation and prothrombin time: a UK field study of two widely used coagulometers. J Clin Pathol 1990;43:679-684
35. 35. Goguel A, Houbouyan LL, Roussi J. Calibrated reference procedure and INR for PT standardisation. Data from the French Etalonorm quality control surveys. Thromb Haemostas 1987; 58(Abst):296
36. 36. Van den Besselaar AMHP. Use of lyophilised calibration plasmas and control blood for INR calculation in external quality assessment of the PT. Am J Clin Pathol 1994;102:123-127
37. 37. Poller L, Triplett DA, Hirsh J, et al. A comparison of lyophilised artificially depleted plasmas and lyophilised plasmas from patients receiving warfarin in correcting for coagulometer effects on INR. Am J Clin Pathol 1995;103:366-371
38. 38. Stevenson KJ, Craig S, Duffy JMK, Taberner DA. System ISI calibration : a universally applicable scheme is possible only when coumarin plasma calibrants are used. Br J Haematol 1997;96:435-441
39. 39. Dufty JMK, Craig S, Stevenson KJ, Taberner DA. Calculation of system ISI: How many calibrants are required?. J Clin Pathol 1997;50:40-44
40. 40. Kitchen S, Jennings I, Woods TAL, Preston FE. Local calibration of INR improves between laboratory agreement: Results from the UK NEQAS. Thromb Haemostas 1999;81:60-65
41. 41. Kitchen S, Jennings I, Woods TAL, Preston FE. Local calibration of thromboplastin/instrument systems for INR determinations: Different calibrants are associated with different INR results. Br J Haematol 1998;101:78(Abst)
42. 42. Loeliger EA, Van den Besselaar AMHP, Lewis SM. Reliability and clinical impact for the normalisation of the prothrombin time. Thromb Haemostas 1985;53:148-154
43. 43. ACCP/NHLBI. National conference on anti-thrombotic therapy. Chest 1986;89(Suppl. 2)
44. 44. Bussey HI, Force FW, Bianco TM, Leonard AD. Reliance on PT ratio causes significant error in anticoagulant therapy. Arch Intern Med 1992;152:278-282
45. 45. Hirsh J. Substandard monitoring of warfarin in North America: Time for change. Arch Intern Med 1992;152:257-258
46. 46. Eckman MH, Levine HJ, Pauker SG. Effect of laboratory uncertainty in the prothrombin time ratio on the results of oral anticoagulant therapy. N Engl J Med 1993;329:696-702
47. 47. Tripodi A, Arbin AA, Chantarangkul V, et al. Are capillary whole blood monitors suitable for the control of oral anticoagulant therapy by the INR? Thromb Haemostas 1993;70:921-924
48. 48. Kitchen S, Preston FE. Monitoring oral anticoagulant therapy with the TAS Near Patient Test System: Comparison with conventional thromboplastins. J Clin Pathol 1997;50:951-956
49. 49. Hasenkam JM, Kinose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardio-Thorac Surg 1997;11:935-942
50. 50. McKernan A, Thomson JM, Poller L. The reliability of the INR during short term oral anticoagulant therapy. Clin Lab Haematol 1988;10:63-71
51. 51. Solomon HM, Randall JR, Simmons VL. Heparin-induced increase in the INR. Responses of 10 commercial thromboplastin reagents. Am J Clin Pathol 1995;103:735-739
52. 52. Moll S, Ortel TL. Monitoring warfarin therapy in patients with Lupus Anticoagulants. Ann Intern Med 1997;127:177-185
53. 53. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 1997; 98:887-892
54. 54. Holland LJ, Lawrie AS, Hunt BJ. Evidence of discrepant commercial ISI assignment. Blood Coag Fibrinolysis 1992;3: 493-494
55. 55. O'Brien WF, Crawford L, Wood DE. Discrepant results in INR testing. Thromb Haemostas 1994;72:986-987
56. 56. Poller L, Taberner DA, Thomson JM, et al. Effect of the choice of WHO international reference preparation for thromboplastin on INR. J Clin Pathol 1993;46:64-66
57. 57. Tripodi A, Chararangkul V, Bragu M, et al. Results of a multi-centre study assessing the status of standardisation of a recombinant thromboplastin for control of oral anticoagulant therapy. Thromb Haemostas 1994;72:261-267
58. 58. Kitchen S, Walker ID, Woods TAL, Preston FE on behalf of the Steering Committee of the UK NEQAS in Blood Coagulation. Thromboplastin related differences in the determination of International Normalised Ratio: A cause for concern? Thromb Haemostas 1994;72:426-429
59. 59. Kitchen S, Jennings I, Woods TAL, Walker ID, Preston FE. Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of INR: A 33 laboratory collaborative study. Thromb Haemostas 1996;76:372-376
60. 60. Preston FE. Quality control and oral anticoagulation. Thromb Haemostas 1995;74:515-520
61. 61. Tripodi A, Poller L, Van den Besselaar AMHP, Mannucci PM. A proposed scheme for calibration of International reference preparations of thromboplastin for the prothrombin time. Thromb Haemostas 1995;74:1368-1369
62. 62. Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International collaborative study for the calibration of a proposed reference preparation for thromboplastin human recombinant plain. Thromb Haemostas 1998;79:439-443